| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | CHD1 CHD2 CHD3 SRCAP CHD6 TTF2 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 3.69e-12 | 37 | 295 | 11 | GO:0140658 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF93 NRIP1 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 NPAS3 ETV1 ETV5 ZNF202 CHD2 KDM6B ZNF442 ZNF440 STAT5B TLX1 ZNF878 ZSCAN1 ZNF556 NFE2L1 UBP1 NTN1 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 UTY ZNF433 NPAS2 ZNF729 ZNF449 ZNF823 ZNF670 TLX3 ZNF300 CHD7 ZNF101 ADNP AR ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF66 ZNF69 SMARCA4 ZNF439 ZNF454 ZNF682 ZNF124 | 3.21e-11 | 1459 | 295 | 56 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 NPAS3 ETV1 ETV5 ZNF202 ZNF442 ZNF440 STAT5B TLX1 ZNF878 ZSCAN1 ZNF556 NFE2L1 UBP1 NTN1 ZNF844 ZNF709 ZNF791 ZNF714 ZNF433 HOMEZ NPAS2 ZNF729 ZNF449 ZNF823 ZNF670 TLX3 ZNF300 ZNF101 ADNP AR ZNF563 HIVEP3 ZNF20 KMT2D ZNF605 ZNF334 ZBED6 ZNF382 ZFP1 ZNF66 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 2.33e-09 | 1412 | 295 | 51 | GO:0000981 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | SETX CHD1 CHD2 CHD3 SRCAP CHD6 TTF2 CHD9 CHD8 CHD7 MLH3 SMARCA2 SMARCA4 TOP2A | 6.03e-09 | 127 | 295 | 14 | GO:0008094 |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 2.69e-08 | 14 | 295 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | helicase activity | SETX CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 9.90e-08 | 158 | 295 | 14 | GO:0004386 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH11 SETX ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 DYNC1I2 TTF2 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 ATAD3A SMARCA2 SMARCA4 MYO15A TOP2A | 4.89e-07 | 614 | 295 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | GPI anchor binding | 8.07e-07 | 23 | 295 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | SETX CHD1 CHD2 CHD3 SRCAP HMCES CHD6 TTF2 CHD9 CHD8 CHD7 FAN1 MLH3 SMARCA2 SMARCA4 TOP2A | 1.95e-06 | 262 | 295 | 16 | GO:0140097 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF93 NRIP1 ZNF136 ZNF444 HIVEP2 ETV1 ZNF202 CHD2 KDM6B STAT5B TLX1 ZSCAN1 NFE2L1 UBP1 NTN1 ZNF763 ZNF844 ZNF564 ZNF709 ZNF714 UTY ZNF433 NPAS2 ZNF729 ZNF449 ZNF670 TLX3 ZNF300 CHD7 ZNF101 AR HIVEP3 ZNF605 ZNF334 ZNF382 ZFP1 ZNF66 SMARCA4 ZNF454 ZNF682 | 2.97e-06 | 1244 | 295 | 40 | GO:0000978 |
| GeneOntologyMolecularFunction | filamin binding | 3.53e-06 | 29 | 295 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.53e-06 | 29 | 295 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF93 NRIP1 ZNF136 ZNF444 HIVEP2 ETV1 ZNF202 CHD2 KDM6B STAT5B TLX1 ZSCAN1 NFE2L1 UBP1 NTN1 ZNF763 ZNF844 ZNF564 ZNF709 ZNF714 UTY ZNF433 NPAS2 ZNF729 ZNF449 ZNF670 TLX3 ZNF300 CHD7 ZNF101 AR HIVEP3 ZNF605 ZNF334 ZNF382 ZFP1 ZNF66 SMARCA4 ZNF454 ZNF682 | 4.98e-06 | 1271 | 295 | 40 | GO:0000987 |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 9.38e-06 | 34 | 295 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 ATAD3A SMARCA4 | 9.96e-06 | 441 | 295 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | histone binding | CHD1 CHD2 CHD3 SRCAP PARP9 CHD6 TBL1X FMR1 CHD8 CHD7 SFMBT2 SBNO2 ZZZ3 SMARCA2 SMARCA4 | 1.02e-05 | 265 | 295 | 15 | GO:0042393 |
| GeneOntologyMolecularFunction | protein phosphatase binding | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 CEACAM7 STRN STX17 CACNA1C FMR1 PPP6R1 | 7.18e-05 | 210 | 295 | 12 | GO:0019903 |
| GeneOntologyMolecularFunction | glycolipid binding | 8.10e-05 | 49 | 295 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | lipid transporter activity | PSG1 PSG2 PSG3 PSG5 ABCA13 PSG6 CEACAM7 ABCG8 ANO4 ESYT1 GRAMD1A | 1.67e-04 | 196 | 295 | 11 | GO:0005319 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH11 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 STRN CAMSAP2 CEP97 CACNA1C MYO15A | 1.69e-04 | 230 | 295 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | AARS1 SETX CHD1 CHD2 CHD3 SRCAP HMCES CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 LARS2 FAN1 MLH3 DROSHA RNASE10 SMARCA2 SMARCA4 TOP2A | 2.54e-04 | 645 | 295 | 22 | GO:0140640 |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 WASHC2A PLA2G4A WASHC2C ESYT1 PLA2G4E ACAP2 GGA1 VPS13B | 2.74e-04 | 316 | 295 | 14 | GO:0035091 |
| GeneOntologyMolecularFunction | phosphatidylinositol-5-phosphate binding | 3.31e-04 | 23 | 295 | 4 | GO:0010314 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.86e-04 | 70 | 295 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | phosphatase binding | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 CEACAM7 STRN STX17 CACNA1C FMR1 PPP6R1 | 5.91e-04 | 264 | 295 | 12 | GO:0019902 |
| GeneOntologyMolecularFunction | chromatin binding | CHD1 CHD2 CHD3 KDM6B SVEP1 STAT5B NFE2L1 CHD6 UTY TBL1X FMR1 CHD8 CHD7 ZNF101 ADNP AR SFMBT2 SBNO2 MLH3 SMARCA2 SMARCA4 SMARCD2 TOP2A | 6.64e-04 | 739 | 295 | 23 | GO:0003682 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate binding | 6.93e-04 | 48 | 295 | 5 | GO:0032266 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 7.34e-04 | 73 | 295 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 NPAS3 IRAK2 TENM2 NFE2L1 ABCG8 FMR1 KATNA1 FXR1 TOP2A | 9.08e-04 | 398 | 295 | 15 | GO:0046982 |
| GeneOntologyMolecularFunction | immunoglobulin receptor activity | 1.03e-03 | 14 | 295 | 3 | GO:0019763 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate binding | 1.07e-03 | 31 | 295 | 4 | GO:0080025 | |
| GeneOntologyMolecularFunction | phospholipid binding | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 WASHC2A PLA2G4A WASHC2C RASA2 ESYT1 CPS1 PLA2G4E MYOF PLA2G4C ACAP2 GGA1 VPS13B | 1.40e-03 | 548 | 295 | 18 | GO:0005543 |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.70e-03 | 149 | 295 | 8 | GO:1990782 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4-phosphate binding | 1.89e-03 | 36 | 295 | 4 | GO:0070273 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.89e-03 | 36 | 295 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 2.11e-03 | 5 | 295 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 2.11e-03 | 5 | 295 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | histone H3K27me2/H3K27me3 demethylase activity | 2.11e-03 | 5 | 295 | 2 | GO:0071558 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.11e-03 | 5 | 295 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 2.18e-03 | 90 | 295 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | calcium-dependent phospholipase A2 activity | 2.21e-03 | 18 | 295 | 3 | GO:0047498 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 RGS20 ATAD3A SMARCA4 RGS17 | 2.74e-03 | 775 | 295 | 22 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | ZNF93 ZNF202 NFE2L1 ZNF844 ZNF709 ZNF433 ZNF729 ZNF670 ZNF101 ZBED6 ZNF382 ZNF682 | 3.01e-03 | 320 | 295 | 12 | GO:0001227 |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 3.02e-03 | 20 | 295 | 3 | GO:0061608 | |
| GeneOntologyMolecularFunction | double-stranded RNA adenosine deaminase activity | 3.14e-03 | 6 | 295 | 2 | GO:0003726 | |
| GeneOntologyMolecularFunction | immune receptor activity | 3.21e-03 | 165 | 295 | 8 | GO:0140375 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 PRUNE2 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 RGS20 ATAD3A SMARCA4 RGS17 | 3.41e-03 | 839 | 295 | 23 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 PRUNE2 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 RGS20 ATAD3A SMARCA4 RGS17 | 3.46e-03 | 840 | 295 | 23 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA13 CHD1 CHD2 CHD3 SRCAP SMPDL3A CHD6 DDX60L ABCG8 PRUNE2 KIF6 DDX49 DNAH2 CHD9 ATP13A5 CHD8 CHD7 KATNA1 MLH3 RGS20 ATAD3A SMARCA4 RGS17 | 3.46e-03 | 840 | 295 | 23 | GO:0016818 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | ZNF93 ZNF202 NFE2L1 ZNF844 ZNF709 ZNF433 ZNF729 ZNF670 ZNF101 ZBED6 ZNF382 ZNF682 | 3.50e-03 | 326 | 295 | 12 | GO:0001217 |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 3.76e-03 | 70 | 295 | 5 | GO:0008235 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.13e-08 | 14 | 293 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.51e-08 | 15 | 293 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.51e-08 | 15 | 293 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.51e-08 | 15 | 293 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.51e-08 | 15 | 293 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 5.55e-08 | 16 | 293 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 8.47e-08 | 17 | 293 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 8.47e-08 | 17 | 293 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 8.47e-08 | 17 | 293 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.26e-07 | 18 | 293 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.56e-07 | 20 | 293 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 3.54e-07 | 21 | 293 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.54e-07 | 21 | 293 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.54e-07 | 21 | 293 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.81e-07 | 22 | 293 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.20e-07 | 35 | 293 | 7 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.43e-07 | 23 | 293 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 6.43e-07 | 23 | 293 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.47e-07 | 24 | 293 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 8.47e-07 | 24 | 293 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.47e-07 | 24 | 293 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.10e-06 | 25 | 293 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.10e-06 | 25 | 293 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.19e-06 | 56 | 293 | 8 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 RASSF5 FCGR2B TWSG1 | 1.61e-06 | 124 | 293 | 11 | GO:0050672 |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.80e-06 | 27 | 293 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 RASSF5 FCGR2B TWSG1 | 1.88e-06 | 126 | 293 | 11 | GO:0032945 |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.26e-06 | 28 | 293 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.82e-06 | 29 | 293 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 RASSF5 FCGR2B TWSG1 | 3.45e-06 | 134 | 293 | 11 | GO:0070664 |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 4.20e-06 | 47 | 293 | 7 | GO:0001911 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 4.24e-06 | 66 | 293 | 8 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 4.26e-06 | 31 | 293 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 5.18e-06 | 32 | 293 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 5.18e-06 | 32 | 293 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 5.18e-06 | 32 | 293 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 5.60e-06 | 49 | 293 | 7 | GO:0002837 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 6.26e-06 | 33 | 293 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 6.26e-06 | 33 | 293 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 6.43e-06 | 50 | 293 | 7 | GO:0002834 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 7.38e-06 | 71 | 293 | 8 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 7.51e-06 | 34 | 293 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 7.51e-06 | 34 | 293 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 8.41e-06 | 52 | 293 | 7 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 MR1 STAT5B FCGR2B PRF1 | 8.43e-06 | 147 | 293 | 11 | GO:0031341 |
| GeneOntologyBiologicalProcess | gland morphogenesis | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 ETV5 NTN1 TWSG1 MMP2 BTRC AR | 9.59e-06 | 178 | 293 | 12 | GO:0022612 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.13e-05 | 124 | 293 | 10 | GO:0001910 | |
| GeneOntologyBiologicalProcess | behavior | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 CEACAM7 NPAS3 ETV1 ETV5 ADARB1 CHRNB1 STRN DDHD2 CNP NPAS2 CACNA1C FMR1 CHD8 CHD7 ADNP AR CELSR1 FXR1 EIF4G1 ASTN1 MYO15A VPS13B GAA PCM1 | 1.16e-05 | 891 | 293 | 30 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.47e-05 | 38 | 293 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 MR1 STAT5B FCGR2B FCGR2C PRF1 | 1.58e-05 | 187 | 293 | 12 | GO:0001909 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.72e-05 | 39 | 293 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.97e-05 | 59 | 293 | 7 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 2.00e-05 | 40 | 293 | 6 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.20e-05 | 60 | 293 | 7 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 2.21e-05 | 107 | 293 | 9 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 2.22e-05 | 134 | 293 | 10 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 2.31e-05 | 41 | 293 | 6 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.36e-05 | 83 | 293 | 8 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 2.66e-05 | 42 | 293 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | IL12RB1 PSG1 TNFSF13 PSG2 PSG3 PSG5 PSG6 CEACAM7 MR1 HMCES SVEP1 STAT5B FCGR2B | 2.96e-05 | 232 | 293 | 13 | GO:0002706 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 3.04e-05 | 63 | 293 | 7 | GO:0007157 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 3.99e-05 | 45 | 293 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.54e-05 | 46 | 293 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.54e-05 | 46 | 293 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 5.14e-05 | 47 | 293 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 5.14e-05 | 47 | 293 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 6.53e-05 | 49 | 293 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 6.78e-05 | 96 | 293 | 8 | GO:0002704 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CADM3 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 FAT2 FAT4 CELSR1 IGSF21 | 7.85e-05 | 187 | 293 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 7.95e-05 | 73 | 293 | 7 | GO:0042304 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 1.00e-04 | 160 | 293 | 10 | GO:0038127 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.02e-04 | 53 | 293 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.03e-04 | 76 | 293 | 7 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte proliferation | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 STAT5B RASSF5 FCGR2B TWSG1 RASAL3 | 1.11e-04 | 301 | 293 | 14 | GO:0050670 |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 1.29e-04 | 134 | 293 | 9 | GO:0045638 | |
| GeneOntologyBiologicalProcess | regulation of mononuclear cell proliferation | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 STAT5B RASSF5 FCGR2B TWSG1 RASAL3 | 1.32e-04 | 306 | 293 | 14 | GO:0032944 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 1.42e-04 | 80 | 293 | 7 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of T cell proliferation | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 STAT5B TWSG1 RASAL3 | 1.50e-04 | 236 | 293 | 12 | GO:0042129 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CADM3 IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 PKD1L1 CEACAM7 ADGRV1 ITGAE TENM2 ITGB5 SVEP1 STAT5B FAT2 NTN1 LRRC7 TWSG1 FAT4 CELSR1 RASAL3 RNASE10 SMARCA2 SMARCA4 SMARCD2 ASTN1 IGSF21 CXADR | 1.56e-04 | 1077 | 293 | 31 | GO:0098609 |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.70e-04 | 139 | 293 | 9 | GO:0007173 | |
| GeneOntologyBiologicalProcess | regulation of nucleus organization | 2.01e-04 | 2 | 293 | 2 | GO:1903353 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.05e-04 | 60 | 293 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 2.08e-04 | 85 | 293 | 7 | GO:0002762 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 SVEP1 STRN CGN XIRP2 PKN2 CXADR | 2.21e-04 | 246 | 293 | 12 | GO:0045216 |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.25e-04 | 61 | 293 | 6 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.26e-04 | 114 | 293 | 8 | GO:0045824 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte activation | PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 RASSF5 FCGR2B TWSG1 | 2.27e-04 | 211 | 293 | 11 | GO:0051250 |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 2.41e-04 | 87 | 293 | 7 | GO:0001974 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | IL12RB1 PSG1 TNFSF13 PSG2 PSG3 PSG5 PSG6 LILRB2 CEACAM7 MR1 HMCES SVEP1 STAT5B FCGR2B FCGR2C PRF1 IL21R | 2.55e-04 | 449 | 293 | 17 | GO:0002449 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | IL12RB1 PSG1 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 STAT5B RASSF5 FCGR2B TWSG1 RASAL3 | 3.05e-04 | 332 | 293 | 14 | GO:0070663 |
| GeneOntologyBiologicalProcess | ovulation | 3.39e-04 | 24 | 293 | 4 | GO:0030728 | |
| GeneOntologyBiologicalProcess | lymphocyte activation | IL12RB1 PSG1 TNFSF13 PSG2 PSG3 PSG5 PSG6 LILRB2 LRRC32 CEACAM7 MR1 HMCES STAT5B RASSF5 PTK2B FCGR2B TWSG1 WWP1 CHD7 RASAL3 DROSHA PRF1 IL21R SMARCA2 SMARCA4 SMARCD2 SYVN1 CXADR | 3.45e-04 | 976 | 293 | 28 | GO:0046649 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.77e-04 | 67 | 293 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | regulation of ketone metabolic process | 3.87e-04 | 189 | 293 | 10 | GO:0010565 | |
| GeneOntologyBiologicalProcess | endocytic recycling | 4.13e-04 | 95 | 293 | 7 | GO:0032456 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 4.42e-04 | 69 | 293 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 4.78e-04 | 70 | 293 | 6 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.78e-04 | 70 | 293 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 4.94e-04 | 128 | 293 | 8 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | IL12RB1 PSG1 TNFSF13 PSG2 PSG3 PSG5 PSG6 CEACAM7 MR1 HMCES SVEP1 STAT5B FCGR2B | 5.09e-04 | 309 | 293 | 13 | GO:0002703 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 5.02e-08 | 16 | 292 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | ciliary membrane | 6.99e-05 | 98 | 292 | 8 | GO:0060170 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.52e-07 | 17 | 220 | 6 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 6.32e-07 | 21 | 220 | 6 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.51e-06 | 24 | 220 | 6 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 3.19e-06 | 27 | 220 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 4.00e-06 | 28 | 220 | 6 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 7.52e-06 | 31 | 220 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 7.52e-06 | 31 | 220 | 6 | MP:0008964 | |
| MousePheno | obese | 1.15e-05 | 113 | 220 | 10 | MP:0001261 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.57e-05 | 35 | 220 | 6 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.86e-05 | 36 | 220 | 6 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 3.00e-05 | 39 | 220 | 6 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 6.08e-05 | 44 | 220 | 6 | MP:0031023 | |
| MousePheno | abnormal carbon dioxide production | 8.48e-05 | 67 | 220 | 7 | MP:0008962 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 8.89e-05 | 47 | 220 | 6 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.13e-04 | 49 | 220 | 6 | MP:0020948 | |
| MousePheno | abnormal vascular wound healing | 1.47e-04 | 73 | 220 | 7 | MP:0004883 | |
| MousePheno | decreased cellular glucose uptake | 1.76e-04 | 53 | 220 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 1.95e-04 | 54 | 220 | 6 | MP:0010953 | |
| MousePheno | decreased urine major urinary protein level | 2.47e-04 | 2 | 220 | 2 | MP:0011532 | |
| MousePheno | abnormal cerebellum fissure morphology | 3.01e-04 | 9 | 220 | 3 | MP:0009267 | |
| Domain | KRAB | ZNF93 ZNF136 ZNF627 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 1.34e-16 | 358 | 287 | 33 | PS50805 |
| Domain | KRAB | ZNF93 ZNF136 ZNF627 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 3.28e-16 | 369 | 287 | 33 | SM00349 |
| Domain | KRAB | ZNF93 ZNF136 ZNF627 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 3.55e-16 | 370 | 287 | 33 | IPR001909 |
| Domain | KRAB | ZNF93 ZNF136 ZNF627 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF433 ZNF729 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 9.64e-16 | 358 | 287 | 32 | PF01352 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 5.47e-13 | 694 | 287 | 40 | IPR013087 |
| Domain | SNF2_N | CHD1 CHD2 CHD3 SRCAP CHD6 TTF2 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 9.03e-13 | 32 | 287 | 11 | PF00176 |
| Domain | SNF2_N | CHD1 CHD2 CHD3 SRCAP CHD6 TTF2 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 9.03e-13 | 32 | 287 | 11 | IPR000330 |
| Domain | zf-C2H2 | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 2.30e-12 | 693 | 287 | 39 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 4.29e-12 | 775 | 287 | 41 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 4.65e-12 | 777 | 287 | 41 | PS00028 |
| Domain | - | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 5.37e-12 | 679 | 287 | 38 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 9.97e-12 | 796 | 287 | 41 | IPR015880 |
| Domain | BRK | 1.25e-11 | 6 | 287 | 6 | SM00592 | |
| Domain | BRK_domain | 1.25e-11 | 6 | 287 | 6 | IPR006576 | |
| Domain | BRK | 1.25e-11 | 6 | 287 | 6 | PF07533 | |
| Domain | Znf_C2H2 | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 1.42e-11 | 805 | 287 | 41 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ADNP ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF654 ZNF682 ZNF124 | 1.59e-11 | 808 | 287 | 41 | SM00355 |
| Domain | zf-C2H2_6 | ZNF93 ZNF136 ZNF627 ZNF442 ZNF440 ZNF878 ZNF556 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF20 ZNF605 ZNF334 ZNF382 ZNF69 ZNF439 ZNF682 | 1.98e-11 | 314 | 287 | 25 | PF13912 |
| Domain | Helicase_C | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.01e-08 | 107 | 287 | 13 | PF00271 |
| Domain | HELICc | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.01e-08 | 107 | 287 | 13 | SM00490 |
| Domain | Helicase_C | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.14e-08 | 108 | 287 | 13 | IPR001650 |
| Domain | DEXDc | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.27e-08 | 109 | 287 | 13 | SM00487 |
| Domain | HELICASE_CTER | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.27e-08 | 109 | 287 | 13 | PS51194 |
| Domain | HELICASE_ATP_BIND_1 | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.27e-08 | 109 | 287 | 13 | PS51192 |
| Domain | Helicase_ATP-bd | CHD1 CHD2 CHD3 SRCAP CHD6 DDX60L TTF2 DDX49 CHD9 CHD8 CHD7 SMARCA2 SMARCA4 | 1.42e-08 | 110 | 287 | 13 | IPR014001 |
| Domain | Chromo_domain | 5.20e-08 | 24 | 287 | 7 | IPR023780 | |
| Domain | Chromo | 9.63e-08 | 26 | 287 | 7 | PF00385 | |
| Domain | CHROMO_2 | 1.69e-07 | 28 | 287 | 7 | PS50013 | |
| Domain | CHROMO_1 | 1.69e-07 | 28 | 287 | 7 | PS00598 | |
| Domain | Chromodomain-like | 4.55e-07 | 32 | 287 | 7 | IPR016197 | |
| Domain | Chromo/shadow_dom | 5.71e-07 | 33 | 287 | 7 | IPR000953 | |
| Domain | CHROMO | 5.71e-07 | 33 | 287 | 7 | SM00298 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 8.75e-07 | 35 | 287 | 7 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 1.58e-06 | 38 | 287 | 7 | PS00690 | |
| Domain | C2 | PLA2G4A FER1L5 RASA2 ESYT1 WWP1 PLA2G4E MYOF RASAL3 PRF1 PKN2 CADPS2 | 1.25e-05 | 142 | 287 | 11 | PS50004 |
| Domain | HSA | 1.42e-05 | 4 | 287 | 3 | SM00573 | |
| Domain | HSA | 1.42e-05 | 4 | 287 | 3 | PS51204 | |
| Domain | HSA_dom | 1.42e-05 | 4 | 287 | 3 | IPR014012 | |
| Domain | HSA | 1.42e-05 | 4 | 287 | 3 | PF07529 | |
| Domain | C2_dom | PLA2G4A FER1L5 RASA2 ESYT1 WWP1 PLA2G4E MYOF RASAL3 PRF1 PKN2 CADPS2 | 4.78e-05 | 164 | 287 | 11 | IPR000008 |
| Domain | C2 | PLA2G4A FER1L5 RASA2 ESYT1 WWP1 PLA2G4E MYOF PRF1 PKN2 CADPS2 | 5.17e-05 | 137 | 287 | 10 | SM00239 |
| Domain | - | PLA2G4A FER1L5 RASA2 ESYT1 WWP1 PLA2G4E MYOF RASAL3 PRF1 PKN2 | 9.91e-05 | 148 | 287 | 10 | 2.60.40.150 |
| Domain | LysoPLipase_cat_dom | 1.20e-04 | 7 | 287 | 3 | IPR002642 | |
| Domain | PLAc | 1.20e-04 | 7 | 287 | 3 | SM00022 | |
| Domain | PLA2_B | 1.20e-04 | 7 | 287 | 3 | PF01735 | |
| Domain | PLA2C | 1.20e-04 | 7 | 287 | 3 | PS51210 | |
| Domain | - | 1.29e-04 | 73 | 287 | 7 | 2.60.120.260 | |
| Domain | C2 | 1.94e-04 | 131 | 287 | 9 | PF00168 | |
| Domain | QLQ | 2.35e-04 | 2 | 287 | 2 | SM00951 | |
| Domain | SnAC | 2.35e-04 | 2 | 287 | 2 | SM01314 | |
| Domain | SnAC | 2.35e-04 | 2 | 287 | 2 | IPR029295 | |
| Domain | Gln-Leu-Gln_QLQ | 2.35e-04 | 2 | 287 | 2 | IPR014978 | |
| Domain | Factor_5/8 | 2.35e-04 | 2 | 287 | 2 | IPR024715 | |
| Domain | SnAC | 2.35e-04 | 2 | 287 | 2 | PF14619 | |
| Domain | QLQ | 2.35e-04 | 2 | 287 | 2 | PS51666 | |
| Domain | QLQ | 2.35e-04 | 2 | 287 | 2 | PF08880 | |
| Domain | FAM21 | 2.35e-04 | 2 | 287 | 2 | IPR027308 | |
| Domain | FA58C_3 | 2.66e-04 | 21 | 287 | 4 | PS50022 | |
| Domain | FA58C | 2.66e-04 | 21 | 287 | 4 | SM00231 | |
| Domain | FA58C_1 | 2.66e-04 | 21 | 287 | 4 | PS01285 | |
| Domain | FA58C_2 | 2.66e-04 | 21 | 287 | 4 | PS01286 | |
| Domain | F5_F8_type_C | 4.55e-04 | 24 | 287 | 4 | PF00754 | |
| Domain | FA58C | 4.55e-04 | 24 | 287 | 4 | IPR000421 | |
| Domain | - | SETX ABCA13 SPEF2 CHD1 CHD2 CHD3 SRCAP SULT1C2 CHD6 DDX60L ABCG8 CNP TTF2 DDX49 DNAH2 CHD9 CHD8 CHD7 KATNA1 SBNO2 ATAD3A SMARCA2 SMARCA4 MYO15A | 5.48e-04 | 746 | 287 | 24 | 3.40.50.300 |
| Domain | V-set | 5.74e-04 | 184 | 287 | 10 | PF07686 | |
| Domain | Galactose-bd-like | 6.16e-04 | 94 | 287 | 7 | IPR008979 | |
| Domain | P-loop_NTPase | MYH11 SETX ABCA13 SPEF2 CHD1 CHD2 CHD3 SRCAP SULT1C2 CHD6 DDX60L ABCG8 CNP TTF2 KIF6 DDX49 DNAH2 CHD9 CHD8 CHD7 KATNA1 SBNO2 ATAD3A SMARCA2 SMARCA4 MYO15A | 6.63e-04 | 848 | 287 | 26 | IPR027417 |
| Domain | Ferlin_A-domain | 6.99e-04 | 3 | 287 | 2 | IPR012560 | |
| Domain | DUF4208 | 6.99e-04 | 3 | 287 | 2 | PF13907 | |
| Domain | FerA | 6.99e-04 | 3 | 287 | 2 | PF08165 | |
| Domain | CAP-ZIP_m | 6.99e-04 | 3 | 287 | 2 | PF15255 | |
| Domain | ETS_PEA3_N | 6.99e-04 | 3 | 287 | 2 | IPR006715 | |
| Domain | Agenet-like_dom | 6.99e-04 | 3 | 287 | 2 | IPR008395 | |
| Domain | FAM21/CAPZIP | 6.99e-04 | 3 | 287 | 2 | IPR029341 | |
| Domain | FXMRP1_C_core | 6.99e-04 | 3 | 287 | 2 | PF12235 | |
| Domain | ETS_PEA3_N | 6.99e-04 | 3 | 287 | 2 | PF04621 | |
| Domain | FerA | 6.99e-04 | 3 | 287 | 2 | SM01200 | |
| Domain | Agenet | 6.99e-04 | 3 | 287 | 2 | PF05641 | |
| Domain | DUF4208 | 6.99e-04 | 3 | 287 | 2 | IPR025260 | |
| Domain | AGENET_LIKE | 6.99e-04 | 3 | 287 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 6.99e-04 | 3 | 287 | 2 | IPR022034 | |
| Domain | DUF4208 | 6.99e-04 | 3 | 287 | 2 | SM01176 | |
| Domain | Ig_2 | 8.98e-04 | 73 | 287 | 6 | PF13895 | |
| Domain | Ig_V-set | 1.05e-03 | 199 | 287 | 10 | IPR013106 | |
| Domain | Gal_mutarotase_N | 1.38e-03 | 4 | 287 | 2 | IPR031727 | |
| Domain | Peroxin/Ferlin | 1.38e-03 | 4 | 287 | 2 | IPR006614 | |
| Domain | DysFC | 1.38e-03 | 4 | 287 | 2 | SM00694 | |
| Domain | DysFN | 1.38e-03 | 4 | 287 | 2 | SM00693 | |
| Domain | REJ | 1.38e-03 | 4 | 287 | 2 | PS51111 | |
| Domain | NtCtMGAM_N | 1.38e-03 | 4 | 287 | 2 | PF16863 | |
| Domain | REJ_dom | 1.38e-03 | 4 | 287 | 2 | IPR014010 | |
| Domain | EGF_1 | TENM2 VWDE ITGB5 SVEP1 FAT2 NTN1 FAT4 CELSR1 PRF1 LRP2 ASTN1 | 2.04e-03 | 255 | 287 | 11 | PS00022 |
| Domain | CarboxyPept-like_regulatory | 2.08e-03 | 17 | 287 | 3 | IPR008969 | |
| Domain | Acyl_Trfase/lysoPLipase | 2.08e-03 | 17 | 287 | 3 | IPR016035 | |
| Domain | Ferlin_B-domain | 2.28e-03 | 5 | 287 | 2 | IPR012561 | |
| Domain | Ferlin_C | 2.28e-03 | 5 | 287 | 2 | PF16165 | |
| Domain | FerIin_dom | 2.28e-03 | 5 | 287 | 2 | IPR012968 | |
| Domain | FerI | 2.28e-03 | 5 | 287 | 2 | PF08151 | |
| Domain | FerB | 2.28e-03 | 5 | 287 | 2 | PF08150 | |
| Domain | Cu-oxidase_3 | 2.28e-03 | 5 | 287 | 2 | IPR011707 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | ZNF136 ZNF627 ZNF202 CHD3 ZNF223 ZNF442 ZNF440 ZNF556 ANAPC2 USP7 CPSF1 MED26 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 TBL1X ZNF729 ZNF670 WWP1 TP53I3 ZNF300 ZNF101 TNRC6C AR ZNF563 HIVEP3 ZNF20 KMT2D ZNF605 ZNF334 ZNF382 ZFP1 SMARCA2 SMARCA4 SMARCD2 ZNF439 ZNF454 ZNF682 ZNF124 | 2.01e-05 | 1387 | 213 | 41 | M734 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.02e-05 | 56 | 213 | 7 | MM17236 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NRIP1 ZNF444 DYM HIVEP2 TTLL3 ETV1 CHD2 CHD3 ADGRV1 ADARB1 ERBIN ITGB5 ZNF440 STAT5B NTN1 LRRC7 CHD6 MMP16 STX17 TBL1X NPAS2 ZNF449 PRUNE2 CACNA1C RASA2 PPFIBP2 WWP1 KSR2 NUCB2 CHD9 ARHGAP39 TNRC6C AR SFMBT2 HPS3 SBNO2 HIVEP3 PACS1 ATAD3A SFXN3 SMARCA2 IFT122 VPS13B PCM1 | 7.56e-13 | 1489 | 297 | 44 | 28611215 |
| Pubmed | 1.01e-11 | 14 | 297 | 7 | 31083261 | ||
| Pubmed | SETX CHD1 CHD2 CHD3 RB1CC1 OLFML3 C9orf43 ALMS1 SUN2 USP7 CHD6 CEP97 KPNA3 KPNA4 FMR1 CHD8 CHD7 LYAR KMT2D FXR1 SMARCA4 SMARCD2 TOP2A | 2.29e-11 | 469 | 297 | 23 | 27634302 | |
| Pubmed | Transcript profiling during preimplantation mouse development. | 9.06e-11 | 18 | 297 | 7 | 15282163 | |
| Pubmed | CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production. | 9.06e-11 | 18 | 297 | 7 | 25692415 | |
| Pubmed | Disruption of Nectin-like 1 cell adhesion molecule leads to delayed axonal myelination in the CNS. | 1.42e-10 | 19 | 297 | 7 | 19036974 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPIRE2 HIVEP2 FYCO1 EXTL3 KDM6B SRCAP WASHC2A SLC29A2 ITGB5 PRR12 TMEM129 USP7 CPSF1 ARHGAP21 CTC1 ESYT1 WWP1 RNPEPL1 KSR2 CHD8 PPP6R1 TNRC6C LARS2 SBNO2 HIVEP3 CCDC88C MYOF CELSR1 KMT2D EIF4G1 NINL SYVN1 GGA1 | 5.51e-10 | 1105 | 297 | 33 | 35748872 |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.02e-10 | 13 | 297 | 6 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.02e-10 | 13 | 297 | 6 | 19273835 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 20044046 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 32150576 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 6265583 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.02e-10 | 13 | 297 | 6 | 12832451 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 25406283 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 8380065 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 1279194 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 25724769 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.02e-10 | 13 | 297 | 6 | 22092845 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.02e-10 | 13 | 297 | 6 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.02e-10 | 13 | 297 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.02e-10 | 13 | 297 | 6 | 23800882 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 19285068 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.02e-10 | 13 | 297 | 6 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.02e-10 | 13 | 297 | 6 | 39168268 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 8402684 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.02e-10 | 13 | 297 | 6 | 21949477 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 26219866 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 2133556 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 19621080 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.02e-10 | 13 | 297 | 6 | 19358828 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 16680193 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.02e-10 | 13 | 297 | 6 | 34058224 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 10964771 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.02e-10 | 13 | 297 | 6 | 23935487 | |
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.02e-10 | 13 | 297 | 6 | 25972571 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.02e-10 | 13 | 297 | 6 | 15220458 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 18843289 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 15207636 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 21081647 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 11133662 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 11483763 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 18003729 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 20739537 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.02e-10 | 13 | 297 | 6 | 27695943 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 20404914 | ||
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.02e-10 | 13 | 297 | 6 | 16638824 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 34440862 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.02e-10 | 13 | 297 | 6 | 21670291 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 22162753 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 2702644 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 11801635 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 21760897 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 1719235 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 16619040 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.02e-10 | 13 | 297 | 6 | 8209741 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 32521208 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 19406938 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.02e-10 | 13 | 297 | 6 | 29967450 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 1653760 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 32169849 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.02e-10 | 13 | 297 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.02e-10 | 13 | 297 | 6 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.02e-10 | 13 | 297 | 6 | 15316023 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 15331748 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.02e-10 | 13 | 297 | 6 | 22406619 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 7628460 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 19008452 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 2164599 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 29396368 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.02e-10 | 13 | 297 | 6 | 33352461 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 38381498 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 1633107 | ||
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.02e-10 | 13 | 297 | 6 | 32027621 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.02e-10 | 13 | 297 | 6 | 27777319 | |
| Pubmed | 6.02e-10 | 13 | 297 | 6 | 18848945 | ||
| Pubmed | NRIP1 CHD3 RB1CC1 PRR12 ALMS1 CHD6 ARHGAP21 KNL1 HOMEZ TBL1X CHD8 ZDBF2 CHD7 PPP6R1 ADNP SFMBT2 KMT2D ZZZ3 LRP2 PCM1 | 7.33e-10 | 418 | 297 | 20 | 34709266 | |
| Pubmed | AARS1 IRAK2 CHD3 ADAR TMEM129 NFE2L1 PARP9 ITPRIPL1 DONSON CHD8 LARS2 MYOF ZBED6 EIF4G1 SMARCA4 TOP2A ALPK2 PCM1 | 7.39e-10 | 332 | 297 | 18 | 37433992 | |
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.05e-09 | 14 | 297 | 6 | 34666041 | |
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 34619794 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 8896983 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 22962327 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 17623671 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 1.05e-09 | 14 | 297 | 6 | 18794798 | |
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 23469261 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 18454175 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 29907459 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 36719377 | ||
| Pubmed | 1.05e-09 | 14 | 297 | 6 | 28567513 | ||
| Interaction | LTBP2 interactions | ZNF136 ZNF627 ZNF444 NUFIP2 ZNF564 ZNF709 ZNF791 ZNF714 CTC1 ZNF101 | 4.20e-07 | 85 | 292 | 10 | int:LTBP2 |
| Interaction | MEX3A interactions | AARS1 IRAK2 CHD3 ADAR TMEM129 NFE2L1 PARP9 ITPRIPL1 FMR1 DONSON CHD8 LARS2 MYOF ZBED6 EIF4G1 SMARCA4 TOP2A ALPK2 PCM1 | 3.68e-06 | 384 | 292 | 19 | int:MEX3A |
| Interaction | CCNDBP1 interactions | ZNF136 ZNF627 ZNF223 ZNF440 ETAA1 ZNF564 ZNF670 ZNF20 ZNF334 ZNF439 ZNF124 | 5.15e-06 | 137 | 292 | 11 | int:CCNDBP1 |
| Interaction | PSG6 interactions | 1.19e-05 | 4 | 292 | 3 | int:PSG6 | |
| Interaction | WWTR1 interactions | TCP11L1 SRCAP ADAR ERBIN ALMS1 CGN USP7 BTRC TTF2 CHD8 ADNP SYAP1 PAICS KMT2D ZZZ3 SMARCA4 PKN2 TOP2A PCM1 | 1.41e-05 | 422 | 292 | 19 | int:WWTR1 |
| Interaction | TPRX2 interactions | 1.58e-05 | 56 | 292 | 7 | int:TPRX2 | |
| Interaction | PBRM1 interactions | CEACAM7 CHD3 ADARB1 TLX1 USP7 FMR1 TLX3 CHD7 AR SMARCA2 SMARCA4 SMARCD2 SYVN1 TOP2A | 2.60e-05 | 258 | 292 | 14 | int:PBRM1 |
| Interaction | GSK3B interactions | AARS1 CHD3 WASHC2A ERBIN HMCES ALMS1 AP1B1 NFE2L1 USP7 CHD6 DDHD2 CAMSAP2 CEP97 ARHGAP21 BTRC DYNC1I2 FMR1 ZDBF2 PPP6R1 LYAR SYAP1 AR MYOF FXR1 TMEM44 EIF4G1 IGSF21 TOP2A PCM1 | 2.69e-05 | 868 | 292 | 29 | int:GSK3B |
| Interaction | KAZALD1 interactions | 2.78e-05 | 13 | 292 | 4 | int:KAZALD1 | |
| Interaction | CCDC136 interactions | ZNF223 ZNF440 ZNF564 DYNC1I2 ZNF670 ZNF20 RASAL3 ZFP1 SMARCA2 PKN2 ZNF124 | 3.73e-05 | 169 | 292 | 11 | int:CCDC136 |
| Interaction | ZNF821 interactions | 5.20e-05 | 15 | 292 | 4 | int:ZNF821 | |
| Cytoband | 19p13.2 | ZNF136 ZNF627 ZNF177 ZNF442 ZNF440 ZNF878 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF433 ZNF823 ZNF563 ZNF20 ZNF69 SMARCA4 ZNF439 | 1.63e-14 | 229 | 297 | 18 | 19p13.2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | IL12RB1 ZNF136 ZNF627 ZNF177 ZNF442 ZNF440 ZNF878 ZNF556 MED26 ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF433 ZNF823 DDX49 ZNF101 SBNO2 ZNF563 ZNF20 RASAL3 ZNF69 SMARCA4 ZNF439 PCSK4 | 2.14e-11 | 797 | 297 | 26 | chr19p13 |
| Cytoband | 19p12 | 2.75e-05 | 90 | 297 | 6 | 19p12 | |
| Cytoband | 17p13.1 | 1.25e-04 | 118 | 297 | 6 | 17p13.1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF93 ZNF136 ZNF627 ZNF444 HIVEP2 ZNF177 ZNF202 ZNF223 ZNF442 ZNF440 ZNF878 ZSCAN1 ZNF556 SCAPER ZNF763 ZNF844 ZNF564 ZNF709 ZNF791 ZNF714 ZNF433 ZNF729 ZNF449 ZNF823 ZNF670 ZNF300 ZNF101 ZNF563 HIVEP3 ZNF20 ZNF605 ZNF334 ZNF382 ZFP1 ZNF69 ZNF439 ZNF454 ZNF682 ZNF124 | 5.72e-16 | 718 | 210 | 39 | 28 |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.80e-08 | 11 | 210 | 5 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.12e-05 | 163 | 210 | 10 | 590 | |
| GeneFamily | Ferlin family | 3.01e-05 | 6 | 210 | 3 | 828 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 7.93e-04 | 4 | 210 | 2 | 1244 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.11e-03 | 18 | 210 | 3 | 596 | |
| GeneFamily | Carboxypeptidases | 1.76e-03 | 21 | 210 | 3 | 1321 | |
| GeneFamily | WASH complex | 1.95e-03 | 6 | 210 | 2 | 1331 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | HIVEP2 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 ADAR STAT5B KPNA3 EIF4G1 | 7.88e-10 | 75 | 295 | 11 | MM605 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SETX HIVEP2 SPEF2 MR1 CHD1 CHD2 CHD3 RB1CC1 ITGAE ADAR ADARB1 ERBIN STAT5B RASSF5 PTK2B SUN2 NUFIP2 PARP9 KPNA4 FMR1 RASA2 ESYT1 SYNE1 GRAMD1A PPP6R1 TNRC6C FHIP2A PNISR SFMBT2 SBNO2 EPG5 HIVEP3 CCDC88C PACS1 KMT2D RASAL3 PRF1 SMARCA2 ACAP2 VPS13B PCM1 RPL19 | 4.22e-08 | 1492 | 295 | 42 | M40023 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 5.98e-08 | 48 | 295 | 8 | MM531 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.09e-07 | 35 | 295 | 7 | MM757 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | NRIP1 PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 EXTL3 STAT5B PTK2B MMP2 FMR1 | 1.15e-06 | 182 | 295 | 12 | MM993 |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.37e-06 | 32 | 295 | 6 | MM2 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 SETX HIVEP2 CHD1 RB1CC1 ADARB1 USP7 KAZN CAMSAP2 BTRC TBL1X KPNA3 WWP1 CHD9 ADNP LARS2 PNISR MYOF FXR1 RGS20 ZZZ3 SMARCA2 PKN2 ACAP2 TOP2A VPS13B | 5.09e-06 | 856 | 295 | 26 | M4500 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 6.34e-06 | 87 | 295 | 8 | MM851 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | PSG1 PSG2 PSG3 PSG5 PSG6 CEACAM7 CHD1 KDM6B STRN RNF10 DYNC1I2 TBL1X PRUNE2 CTC1 ESYT1 WWP1 ADNP ZBED6 GGA1 ZNF654 | 7.95e-06 | 568 | 295 | 20 | MM3824 |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN | TTLL3 ETV1 CHD2 EXTL3 SRCAP SLC29A2 SUN2 UPK3A CNP ZNF101 PLA2G4C | 1.72e-05 | 199 | 295 | 11 | M8289 |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | CHD3 EXTL3 SRCAP SUN2 DDX49 SYNE1 NUCB2 PNISR WTAP NINL VPS13B | 1.80e-05 | 200 | 295 | 11 | M8306 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NRIP1 HIVEP2 CHD1 STRN FAT2 NPAS2 CHD9 ADNP PNISR MLH3 ZZZ3 TOP2A VPS13B | 3.96e-05 | 300 | 295 | 13 | M8702 |
| Coexpression | CERVERA_SDHB_TARGETS_1_DN | 4.94e-05 | 36 | 295 | 5 | M11404 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 5.10e-05 | 224 | 295 | 11 | M40145 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | NRIP1 TNFSF13 MR1 STRN GCLM PLA2G4A C3AR1 KPNA3 RASA2 CHD9 PNISR CCDC88C FXR1 PRF1 EIF4G1 | 5.72e-05 | 402 | 295 | 15 | M5275 |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 5.91e-05 | 152 | 295 | 9 | M2964 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP | AARS1 PSG3 ZNF177 SULT1C2 PIGR NPAS2 PPFIBP2 DNAH2 CPB1 RNF17 | 8.48e-05 | 197 | 295 | 10 | M6278 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 HIVEP2 CHD1 ADARB1 CAMSAP2 TBL1X KPNA3 CHD9 LARS2 PNISR FXR1 RGS20 ZZZ3 SMARCA2 PKN2 TOP2A | 8.67e-05 | 466 | 295 | 16 | M13522 |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN | CHD3 HMCES SMPDL3A UBP1 TTF2 HTR3A RASA2 PPP6R1 IL21R SMARCA4 | 8.84e-05 | 198 | 295 | 10 | M3195 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 9.22e-05 | 199 | 295 | 10 | M9443 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 9.61e-05 | 200 | 295 | 10 | M9439 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 9.61e-05 | 200 | 295 | 10 | M7502 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | ETV1 FYCO1 PTK2B RASA2 NUCB2 CHD7 CCDC88C KMT2D RASAL3 IL21R | 9.61e-05 | 200 | 295 | 10 | M5063 |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | FYCO1 CHD3 EXTL3 PTK2B PARP9 MMP16 TBL1X RASA2 CCDC88C SMARCA2 | 9.61e-05 | 200 | 295 | 10 | M5059 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.04e-04 | 128 | 295 | 8 | MM1000 | |
| Coexpression | HADDAD_B_LYMPHOCYTE_PROGENITOR | LILRB2 ZNF177 RB1CC1 HMCES AP1B1 HPS4 FMR1 CHD7 PNISR SMARCA4 PKN2 TOP2A | 1.21e-04 | 290 | 295 | 12 | M939 |
| Coexpression | IBRAHIM_NRF2_UP | ETV5 RB1CC1 WASHC2A GCLM NUFIP2 RNF10 TWSG1 KPNA4 WASHC2C WWP1 NUCB2 LYAR MLH3 FXR1 RGS20 ZZZ3 ACAP2 | 1.28e-04 | 533 | 295 | 17 | M42510 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.51e-04 | 135 | 295 | 8 | MM965 | |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP | 1.64e-04 | 46 | 295 | 5 | M41048 | |
| Coexpression | QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP | 1.64e-04 | 46 | 295 | 5 | M41047 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 1.85e-04 | 139 | 295 | 8 | M8948 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | SETX PEG10 ETV1 CHD1 EXTL3 KDM6B STAT5B ZDHHC15 C3AR1 TWSG1 MMP16 CAMSAP2 ITPRIPL1 TBL1X FAM171B AR KLHL11 VPS13B CXADR | 1.07e-06 | 369 | 294 | 19 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | MYH11 SETX PEG10 NPAS3 ETV1 CHD1 EXTL3 KDM6B TENM2 STAT5B ZDHHC15 C3AR1 TWSG1 MMP16 CAMSAP2 ITPRIPL1 TBL1X ZNF823 FAT4 DPP10 CPB1 FAM171B AR KLHL11 ASTN1 VPS13B CXADR | 2.28e-05 | 806 | 294 | 27 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | SETX HIVEP2 LRRC32 CHD3 ZDHHC15 CEP97 CNP USP28 GRAMD1A CHD7 AR PACS1 CELSR1 RASAL3 PRF1 IL21R | 4.47e-05 | 359 | 294 | 16 | GSM404000_500 |
| CoexpressionAtlas | alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2 | NRIP1 HIVEP2 CHD3 KDM6B OLFML3 ZDHHC15 NTN1 CEP97 RASA2 GRAMD1A CHD7 SFMBT2 RASAL3 ATAD3A IL21R | 5.78e-05 | 328 | 294 | 15 | GSM605756_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#1 | CADM3 TCP11L1 TWSG1 CEP97 CHD7 LARS2 CCDC88C CELSR1 RGS20 STON2 LRP2 SMARCA4 NINL RGS17 | 6.87e-05 | 295 | 294 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | NPAS3 CHD1 ALMS1 FMR1 CHD8 ZDBF2 CHD7 FAM171B LARS2 CCDC88C ZNF605 NINL ASTN1 RGS17 | 7.65e-05 | 298 | 294 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | MR1 FYCO1 ITGB5 OLFML3 SUN2 PLA2G4A KAZN MMP2 ZNHIT2 CACNA1C FAT4 CPXM2 PPFIBP2 SYNE1 PHF24 DNAH2 RASAL3 TMEM44 CPXM1 IFT122 PCSK4 | 7.98e-05 | 589 | 294 | 21 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Papillary-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | ZNF136 ZNF440 ZNF878 ZNF763 ZNF433 ZNF823 ZNF101 ZNF20 ZNF69 ZNF682 | 3.87e-09 | 111 | 297 | 10 | eb737146969b70c619649f244998d4183237c763 |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CADM3 SPEF2 PRR12 PLA2G4A STX17 HOMEZ NPAS2 SFMBT2 ZZZ3 TMEM44 CPXM1 | 5.02e-08 | 185 | 297 | 11 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | CADM3 SPEF2 PRR12 PLA2G4A STX17 HOMEZ NPAS2 SFMBT2 ZZZ3 TMEM44 CPXM1 | 5.02e-08 | 185 | 297 | 11 | 02cbf492bc40abebaa93a3a208888afae72fbe06 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | TBC1D8B ZNF556 ZNF709 ITPRIPL1 RASA2 USP28 SYNE1 RASAL3 XIRP2 PRF1 | 1.21e-07 | 159 | 297 | 10 | bf8ff9251bcb64b2b9d6dd93461aec97659686ec |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ABCA13 ADGRV1 F5 LRRC7 CACNA1C DPP10 ATP13A5 CPS1 LARS2 SFMBT2 | 1.44e-07 | 162 | 297 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SETX PTK2B AP1B1 SUN2 ESYT1 GRAMD1A ADNP LARS2 HIVEP3 RASAL3 | 4.94e-07 | 185 | 297 | 10 | a2cae8c657e4f4d121476798e424876f7e247973 |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | MANBA IRAK2 RIPOR3 CHD2 KDM6B RASSF5 PTK2B WTAP HIVEP3 VPS13B | 4.94e-07 | 185 | 297 | 10 | a72ccb147ca505880e2da8f6a70b9d570464a691 |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SETX PTK2B AP1B1 SUN2 ESYT1 GRAMD1A ADNP LARS2 HIVEP3 RASAL3 | 4.94e-07 | 185 | 297 | 10 | d50406a9a5b8d75110ba5985741aa2293950c543 |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | PDZD7 ADARB1 ITGB5 OLFML3 PLA2G4A MMP2 KIAA2012 CPXM2 PPFIBP2 CPXM1 | 5.19e-07 | 186 | 297 | 10 | 4e983de6d2515082f9e555f4f949cec84281c140 |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.01e-07 | 189 | 297 | 10 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.62e-07 | 199 | 297 | 10 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.01e-06 | 200 | 297 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-06 | 169 | 297 | 9 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 172 | 297 | 9 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 176 | 297 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 176 | 297 | 9 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 176 | 297 | 9 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 176 | 297 | 9 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.01e-06 | 188 | 297 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.01e-06 | 188 | 297 | 9 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-06 | 191 | 297 | 9 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-06 | 191 | 297 | 9 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.69e-06 | 191 | 297 | 9 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.94e-06 | 192 | 297 | 9 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-06 | 145 | 297 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.19e-06 | 193 | 297 | 9 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.19e-06 | 193 | 297 | 9 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.19e-06 | 193 | 297 | 9 | b38aaffbea36ef6c08ebe82675438f873c89b242 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition_(most_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.19e-06 | 193 | 297 | 9 | a6a864644e1b80b7417ea0a27281e79068a3fd3d | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 6.46e-06 | 194 | 297 | 9 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 194 | 297 | 9 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | facs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 194 | 297 | 9 | f1661f9f2439fca5c1012c693b0744c4e3b90a9b | |
| ToppCell | facs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 194 | 297 | 9 | cda1b197efb199330ea7ab25a7cee22cae22589d | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.46e-06 | 194 | 297 | 9 | 66c056232ac216780acf4cc8ea325bd8ed1909c9 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 195 | 297 | 9 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.31e-06 | 197 | 297 | 9 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.61e-06 | 198 | 297 | 9 | 9b1a58fcf818f9c4ae57bbe99655f0a64fe87df7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.25e-06 | 200 | 297 | 9 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 8.25e-06 | 200 | 297 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 155 | 297 | 8 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.76e-06 | 155 | 297 | 8 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-05 | 163 | 297 | 8 | 4b8abbad4df040c895e3afb240759ebbc66b4d0e | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.83e-05 | 169 | 297 | 8 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 169 | 297 | 8 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.88e-05 | 123 | 297 | 7 | 511b7c20a4a85e49980936d52af7dbca19bb848e | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 2.07e-05 | 172 | 297 | 8 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 174 | 297 | 8 | e2243f1e48e3275753a2b3a69d06eefce69a8ded | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.45e-05 | 176 | 297 | 8 | 0923b01137d6f9956ca815b41102c81e82624065 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 178 | 297 | 8 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 178 | 297 | 8 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 179 | 297 | 8 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-05 | 179 | 297 | 8 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 179 | 297 | 8 | f14440f6ce9b4fcdd4bcb2488b949f9a0e17bc23 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 179 | 297 | 8 | 6f51a4580c06fc55cc764052c9b26f7c55660282 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 179 | 297 | 8 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | facs-Pancreas-Endocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 179 | 297 | 8 | a6ce1fa338d4905bd6afef00763ac83e916a0b37 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.76e-05 | 179 | 297 | 8 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-05 | 180 | 297 | 8 | 4e9e8cde2919610c4ac0025b1c9819808048bc1d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-05 | 180 | 297 | 8 | ca2a35bfb67347e47f511589a3d0f763e6664634 | |
| ToppCell | facs-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-05 | 180 | 297 | 8 | c0c3144011856d005aebd5cdc79f89fee32083a8 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.87e-05 | 180 | 297 | 8 | 466381bf93c3da6a2a241daadb68e9aad2964eae | |
| ToppCell | cellseq2-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-NK|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.11e-05 | 182 | 297 | 8 | 8ccffcbae28c374fd4161fb0d4cf2c49fae557f6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 186 | 297 | 8 | d1d01ce46e62944aa9864eda47e8401b5f0d2bdc | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.77e-05 | 187 | 297 | 8 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.77e-05 | 187 | 297 | 8 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 188 | 297 | 8 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-05 | 188 | 297 | 8 | 013162466a3334b6967c0cb670c8577d809b1396 | |
| ToppCell | normal-na-Hematopoietic-progenitor_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.92e-05 | 188 | 297 | 8 | be25371e6459504b5f0c9ece3a0fe8f80c7824ca | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.92e-05 | 188 | 297 | 8 | 6c7ce6e28e4433092605880acf127833e7b66ebe | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 188 | 297 | 8 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.92e-05 | 188 | 297 | 8 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.22e-05 | 190 | 297 | 8 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.22e-05 | 190 | 297 | 8 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-C|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.22e-05 | 190 | 297 | 8 | 259085b9731902ca0956233afafe1db6fc98e851 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-05 | 192 | 297 | 8 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 192 | 297 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.54e-05 | 192 | 297 | 8 | 72881b280a415e65f87a80ca1369cbb0b722a0c4 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.71e-05 | 193 | 297 | 8 | b637e1c47a98009e7d19a6daac78f888fd12748f | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.71e-05 | 193 | 297 | 8 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.89e-05 | 194 | 297 | 8 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.89e-05 | 194 | 297 | 8 | f2f7b9aad7588c8020a4850ff9333e1db8eafac7 | |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 194 | 297 | 8 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 4.89e-05 | 194 | 297 | 8 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | (4)_Endothelial_cells-(42)_EC-sinusoidal|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.89e-05 | 194 | 297 | 8 | 4428b472c2042f88eae028b1770767512a515b75 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.89e-05 | 194 | 297 | 8 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.07e-05 | 195 | 297 | 8 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.07e-05 | 195 | 297 | 8 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.07e-05 | 195 | 297 | 8 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.07e-05 | 195 | 297 | 8 | cab90c67a7b3119c0d0d2d5e84511c41dcb8765f | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 196 | 297 | 8 | 6730743cf088c419ccc2d28765769fc09d3ba6a7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.26e-05 | 196 | 297 | 8 | c57a95f8b4d8d6334f269d3c16246684f4222a3e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-05 | 196 | 297 | 8 | 21dab89f3699037138a9c7a0e4dc98739a9fad9c | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 5.45e-05 | 197 | 297 | 8 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-05 | 197 | 297 | 8 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 197 | 297 | 8 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 197 | 297 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.45e-05 | 197 | 297 | 8 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 197 | 297 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.45e-05 | 197 | 297 | 8 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | distal-Epithelial-Ionocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.45e-05 | 197 | 297 | 8 | 11a5d2db2561d045756980ead61e1211c7dda100 | |
| Computational | Neighborhood of EGFR | 1.09e-05 | 32 | 175 | 6 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 1.87e-05 | 35 | 175 | 6 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 5.51e-05 | 42 | 175 | 6 | GNF2_MMP11 | |
| Computational | Neighborhood of CDKN1C | 6.52e-05 | 27 | 175 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of TIMP2 | 9.33e-05 | 46 | 175 | 6 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.34e-04 | 49 | 175 | 6 | GNF2_KISS1 | |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | IL12RB1 HIVEP2 ETV5 KDM6B CHRNB1 STRN SCAPER KAZN MMP16 PACS1 MYOF SFXN3 GGA1 | 1.81e-06 | 198 | 292 | 13 | 2791_UP |
| Drug | pP-8 | 5.24e-06 | 10 | 292 | 4 | CID000444681 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | ZNF93 HIVEP2 EXTL3 F5 SVEP1 PIGR EPS8L3 BTRC PHF24 ASTN1 CADPS2 VPS13B | 9.25e-06 | 196 | 292 | 12 | 6169_UP |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | ETV1 ETV5 TBC1D8B ADARB1 HPS4 USP7 C3AR1 NPAS2 CTC1 SBNO2 ASTN1 PCM1 | 9.74e-06 | 197 | 292 | 12 | 4089_DN |
| Drug | Dropropizine (R,S) [17692-31-8]; Down 200; 17uM; HL60; HT_HG-U133A | TCP11L1 ZNF202 ANAPC2 SCAPER ETAA1 CEP97 TBL1X SBNO2 FRY LRP2 GGA1 PCM1 | 1.03e-05 | 198 | 292 | 12 | 2398_DN |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | ZNF444 TCP11L1 EXTL3 CHRNB1 KAZN MMP16 PPFIBP2 SYNE1 CPS1 PACS1 PRF1 PCM1 | 1.13e-05 | 200 | 292 | 12 | 3425_UP |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.74e-09 | 7 | 287 | 5 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Schizophrenia | NRIP1 DYM TNFSF13 ABCA13 NPAS3 RB1CC1 ADARB1 HPS4 NUFIP2 PLA2G4A CNP NPAS2 KPNA3 CACNA1C FMR1 HTR3A ADNP LARS2 SBNO2 PLA2G4C STON2 SMARCA2 LRP2 CADPS2 PCM1 | 2.11e-06 | 883 | 287 | 25 | C0036341 |
| Disease | Premature atrial contractions | 1.56e-05 | 55 | 287 | 6 | HP_0006699 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.92e-05 | 152 | 287 | 9 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | TTLL3 TNFSF13 ABCA13 ETV1 CHD1 ZNF442 F5 ETAA1 MMP2 CAMSAP2 DONSON SYNE1 RNPEPL1 HPS3 HIVEP3 MLH3 ZZZ3 EIF4G1 LRP2 IGSF21 | 2.08e-05 | 702 | 287 | 20 | C0009402 |
| Disease | cD177 antigen measurement | 2.41e-05 | 18 | 287 | 4 | EFO_0021866 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 3.10e-05 | 7 | 287 | 3 | DOID:11724 (implicated_via_orthology) | |
| Disease | Intellectual Disability | HIVEP2 CHD3 KDM6B PRR12 AP1B1 SCAPER DYNC1I2 FMR1 SYNE1 CHD8 FHIP2A PACS1 FRY LRP2 ASTN1 | 3.70e-05 | 447 | 287 | 15 | C3714756 |
| Disease | congenital heart disease (implicated_via_orthology) | 5.76e-05 | 69 | 287 | 6 | DOID:1682 (implicated_via_orthology) | |
| Disease | USHER SYNDROME, TYPE IIC | 9.43e-05 | 2 | 287 | 2 | 605472 | |
| Disease | Usher syndrome type 2C | 9.43e-05 | 2 | 287 | 2 | cv:C2931213 | |
| Disease | Usher syndrome, type 2C | 9.43e-05 | 2 | 287 | 2 | C2931213 | |
| Disease | Usher syndrome type 2C (is_implicated_in) | 9.43e-05 | 2 | 287 | 2 | DOID:0110839 (is_implicated_in) | |
| Disease | eosinophil percentage of leukocytes | NRIP1 HIVEP2 ZNF177 SPEF2 LRRC32 MR1 IRAK2 CHD1 KDM6B PTK2B ANAPC2 C16orf96 CHD7 CPS1 SBNO2 HIVEP3 CELSR1 ZFP1 ALPK2 | 1.46e-04 | 746 | 287 | 19 | EFO_0007991 |
| Disease | platelet component distribution width | NRIP1 HIVEP2 TCP11L1 ETV5 RIPOR3 SVEP1 TLX1 FCGR2B NFE2L1 USP7 NPAS2 PRUNE2 CACNA1C SYNE1 RNPEPL1 CPS1 PKN2 DEPDC7 GAA | 1.70e-04 | 755 | 287 | 19 | EFO_0007984 |
| Disease | Autistic Disorder | 2.59e-04 | 261 | 287 | 10 | C0004352 | |
| Disease | Kabuki syndrome (implicated_via_orthology) | 2.81e-04 | 3 | 287 | 2 | DOID:0060473 (implicated_via_orthology) | |
| Disease | fragile X syndrome (implicated_via_orthology) | 2.81e-04 | 3 | 287 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 2.81e-04 | 3 | 287 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | Metabolic Bone Disorder | 3.06e-04 | 14 | 287 | 3 | C0005944 | |
| Disease | Ischemic stroke | CHD3 F5 VWDE HPS4 ARHGAP21 HTR3A USP28 RNF17 EPG5 FXR1 SMARCA4 | 3.63e-04 | 324 | 287 | 11 | HP_0002140 |
| Disease | Osteopenia | 3.80e-04 | 15 | 287 | 3 | C0029453 | |
| Disease | Malignant neoplasm of prostate | ETV1 ETV5 CHD1 CHD3 USP7 CHD6 EPS8L3 USP28 PPFIBP2 NUCB2 CHD7 AR KMT2D ATAD3A LRP2 TOP2A | 3.91e-04 | 616 | 287 | 16 | C0376358 |
| Disease | Prostatic Neoplasms | ETV1 ETV5 CHD1 CHD3 USP7 CHD6 EPS8L3 USP28 PPFIBP2 NUCB2 CHD7 AR KMT2D ATAD3A LRP2 TOP2A | 3.91e-04 | 616 | 287 | 16 | C0033578 |
| Disease | netrin-1 measurement | 5.58e-04 | 4 | 287 | 2 | EFO_0022009 | |
| Disease | syndrome (implicated_via_orthology) | 6.67e-04 | 18 | 287 | 3 | DOID:225 (implicated_via_orthology) | |
| Disease | eosinophil count | NRIP1 HIVEP2 PSG1 ZNF177 SPEF2 LRRC32 MR1 IRAK2 CHD1 KDM6B SVEP1 STAT5B PTK2B USP7 FER1L5 KIAA2012 RASA2 NUCB2 C16orf96 CHD7 CPS1 SBNO2 HIVEP3 CELSR1 RASAL3 SMARCA4 PKN2 ALPK2 | 6.92e-04 | 1488 | 287 | 28 | EFO_0004842 |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 7.86e-04 | 19 | 287 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 7.86e-04 | 19 | 287 | 3 | C2936783 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 7.86e-04 | 19 | 287 | 3 | DOID:9562 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 8.69e-04 | 156 | 287 | 7 | DOID:10283 (is_marker_for) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 9.25e-04 | 5 | 287 | 2 | C3281201 | |
| Disease | Substance abuse problem | 9.75e-04 | 116 | 287 | 6 | C0740858 | |
| Disease | uric acid measurement | ETV5 CHD2 ADGRV1 F5 SLC29A2 TENM2 NPAS2 FAT4 CPS1 AR PACS1 MYOF RGS20 LRP2 IPO11 | 1.02e-03 | 610 | 287 | 15 | EFO_0004761 |
| Disease | platelet measurement | 1.11e-03 | 315 | 287 | 10 | EFO_0005036 | |
| Disease | schizophrenia, anorexia nervosa | 1.22e-03 | 48 | 287 | 4 | MONDO_0005090, MONDO_0005351 | |
| Disease | cotinine measurement, trans-3-hydroxycotinine measurement | 1.38e-03 | 6 | 287 | 2 | EFO_0007813, EFO_0010707 | |
| Disease | age at diagnosis, coronary atherosclerosis measurement | 1.38e-03 | 6 | 287 | 2 | EFO_0004918, EFO_0007938 | |
| Disease | Immunologic Deficiency Syndromes | 1.40e-03 | 23 | 287 | 3 | C0021051 | |
| Disease | unipolar depression, neuroticism measurement | 1.58e-03 | 24 | 287 | 3 | EFO_0003761, EFO_0007660 | |
| Disease | white matter microstructure measurement | SPIRE2 EXTL3 TENM2 STRN SUN2 SCAPER NTN1 ARHGAP21 LRP2 PKN2 MAP3K13 | 1.64e-03 | 390 | 287 | 11 | EFO_0005674 |
| Disease | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.76e-03 | 53 | 287 | 4 | C1961099 | |
| Disease | vitamin D measurement | NRIP1 ADAR ZNF440 UGT2B10 NPAS2 C16orf96 ZNF101 CPS1 SMARCA4 ZNF439 | 1.79e-03 | 336 | 287 | 10 | EFO_0004631 |
| Disease | bipolar disorder (implicated_via_orthology) | 1.92e-03 | 7 | 287 | 2 | DOID:3312 (implicated_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 1.92e-03 | 7 | 287 | 2 | C1531647 | |
| Disease | Communicating Hydrocephalus | 1.92e-03 | 7 | 287 | 2 | C0009451 | |
| Disease | Hermansky-Pudlak syndrome (is_implicated_in) | 1.92e-03 | 7 | 287 | 2 | DOID:3753 (is_implicated_in) | |
| Disease | Fetal Cerebral Ventriculomegaly | 1.92e-03 | 7 | 287 | 2 | C2936718 | |
| Disease | retinal vein occlusion (is_implicated_in) | 1.92e-03 | 7 | 287 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | Obstructive Hydrocephalus | 1.92e-03 | 7 | 287 | 2 | C0549423 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 1.92e-03 | 7 | 287 | 2 | EFO_0801906 | |
| Disease | Hydrocephalus Ex-Vacuo | 1.92e-03 | 7 | 287 | 2 | C0270720 | |
| Disease | Post-Traumatic Hydrocephalus | 1.92e-03 | 7 | 287 | 2 | C0477432 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.01e-03 | 26 | 287 | 3 | C0009405 | |
| Disease | Antithrombotic agent use measurement | 2.02e-03 | 55 | 287 | 4 | EFO_0009925 | |
| Disease | hippocampal atrophy | 2.16e-03 | 56 | 287 | 4 | EFO_0005039 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 2.24e-03 | 27 | 287 | 3 | C1112155 | |
| Disease | Sezary Syndrome | 2.24e-03 | 27 | 287 | 3 | C0036920 | |
| Disease | Myocardial Infarction | 2.39e-03 | 95 | 287 | 5 | C0027051 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 2.51e-03 | 352 | 287 | 10 | EFO_0007014 | |
| Disease | mean platelet volume | MYH11 HIVEP2 SRCAP SVEP1 RASSF5 STRN C9orf43 AP1B1 NFE2L1 USP7 DNAJC12 ABCG8 HOMEZ RNPEPL1 NUCB2 CHD9 CHD7 CPS1 FRY ACAP2 | 2.52e-03 | 1020 | 287 | 20 | EFO_0004584 |
| Disease | Aqueductal Stenosis | 2.54e-03 | 8 | 287 | 2 | C2936786 | |
| Disease | Congenital Hydrocephalus | 2.54e-03 | 8 | 287 | 2 | C0020256 | |
| Disease | triacylglycerol 58:6 measurement | 2.54e-03 | 8 | 287 | 2 | EFO_0010440 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.76e-03 | 29 | 287 | 3 | C1333990 | |
| Disease | gas trapping measurement | 2.76e-03 | 29 | 287 | 3 | EFO_0007628 | |
| Disease | Adenoid Cystic Carcinoma | 2.98e-03 | 100 | 287 | 5 | C0010606 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 3.04e-03 | 30 | 287 | 3 | DOID:332 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.10e-03 | 195 | 287 | 7 | DOID:1574 (implicated_via_orthology) | |
| Disease | carboxypeptidase B measurement | 3.24e-03 | 9 | 287 | 2 | EFO_0801453 | |
| Disease | malaria (implicated_via_orthology) | 3.24e-03 | 9 | 287 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 3.24e-03 | 9 | 287 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Hydrocephalus | 3.24e-03 | 9 | 287 | 2 | C0020255 | |
| Disease | plexin-B2 measurement | 3.24e-03 | 9 | 287 | 2 | EFO_0021867 | |
| Disease | Hypermetropia | 3.39e-03 | 103 | 287 | 5 | HP_0000540 | |
| Disease | prostate cancer (implicated_via_orthology) | 4.00e-03 | 33 | 287 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | abdominal aortic aneurysm (is_marker_for) | 4.03e-03 | 10 | 287 | 2 | DOID:7693 (is_marker_for) | |
| Disease | response to hydrochlorothiazide, diastolic blood pressure change measurement | 4.03e-03 | 10 | 287 | 2 | EFO_0005202, EFO_0006945 | |
| Disease | membranoproliferative glomerulonephritis (biomarker_via_orthology) | 4.03e-03 | 10 | 287 | 2 | DOID:2920 (biomarker_via_orthology) | |
| Disease | Hermanski-Pudlak Syndrome | 4.03e-03 | 10 | 287 | 2 | C0079504 | |
| Disease | Facies | 4.03e-03 | 10 | 287 | 2 | C0282631 | |
| Disease | Hermansky-Pudlak syndrome | 4.03e-03 | 10 | 287 | 2 | cv:C0079504 | |
| Disease | interleukin-6 measurement | 4.84e-03 | 112 | 287 | 5 | EFO_0004810 | |
| Disease | Macrocephaly | 4.89e-03 | 11 | 287 | 2 | C0221355 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 4.89e-03 | 11 | 287 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 4.89e-03 | 11 | 287 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Alcoholic Intoxication, Chronic | 4.93e-03 | 268 | 287 | 8 | C0001973 | |
| Disease | obesity (implicated_via_orthology) | 5.27e-03 | 215 | 287 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | Prescription Drug Abuse | 5.41e-03 | 115 | 287 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 5.41e-03 | 115 | 287 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.41e-03 | 115 | 287 | 5 | C0029231 | |
| Disease | Drug habituation | 5.41e-03 | 115 | 287 | 5 | C0013170 | |
| Disease | Drug abuse | 5.41e-03 | 115 | 287 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 5.41e-03 | 115 | 287 | 5 | C0013222 | |
| Disease | Drug Dependence | 5.41e-03 | 115 | 287 | 5 | C1510472 | |
| Disease | Substance Dependence | 5.41e-03 | 115 | 287 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 5.41e-03 | 115 | 287 | 5 | C0038586 | |
| Disease | serum albumin measurement | TNFSF13 ADGRV1 ADAR SVEP1 PRR12 FCGR2B UBP1 SH2D7 GRAMD1A ZNF101 FCGR2C FRY GGA1 | 5.63e-03 | 592 | 287 | 13 | EFO_0004535 |
| Disease | creatinine measurement, glomerular filtration rate | 5.81e-03 | 117 | 287 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | intracranial aneurysm (is_implicated_in) | 5.83e-03 | 12 | 287 | 2 | DOID:10941 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PLANDVVEQWKTNEA | 121 | Q5JXB2 | |
| DTQLNWNIVSFPVAE | 111 | Q9GZX9 | |
| SENDERLSNPQIEWQ | 1051 | Q9H2P0 | |
| RLSNPQIEWQNSTID | 1056 | Q9H2P0 | |
| DNESFNPSLWEEQRK | 441 | Q96RT1 | |
| TAPELILDQWFQLSS | 566 | Q9BSJ8 | |
| PWILVLEDNESSQQR | 1971 | Q9HCE0 | |
| EEFVPASVTWQLVEN | 751 | Q4VNC0 | |
| IFDSDWNPQNDLQAQ | 1226 | Q9HCK8 | |
| ENRTDISLDDPNFWQ | 1361 | Q9HCK8 | |
| NDLQANISPEFWNAI | 81 | Q9UJX6 | |
| NWPLEVLVTDSVQNS | 541 | Q9NQ75 | |
| AQVPSSEQAWLEDAQ | 6 | Q2NKJ3 | |
| QVNTLFETSQVPDWS | 636 | Q86TB3 | |
| SNQPEQFDWAINDRI | 501 | Q9NVI7 | |
| LNEWSSQINPDLVRE | 51 | P48507 | |
| TILIWDFLNDPAAQA | 576 | Q9Y297 | |
| PQWINVLQEDSVTLT | 56 | P31994 | |
| NVAVSDDWTLDVQPN | 4091 | Q6V0I7 | |
| QWNPEDFDNITKLSI | 96 | P46098 | |
| SVSWQLFQNDSALQP | 1151 | Q8WXG9 | |
| WPENNLADKDQVSVA | 356 | Q8TCU4 | |
| NFADLNTPLWEAQDD | 436 | Q96SM3 | |
| PFQQWEALNDSVKTS | 86 | Q9UKB3 | |
| ESVWLPDVVLLNNND | 106 | P11230 | |
| LEDLDWLPLNQTFSQ | 216 | Q86UQ4 | |
| WLPLNQTFSQVSELV | 221 | Q86UQ4 | |
| VDLASQVPWFEQLAQ | 56 | Q9H221 | |
| NAIPENKDLVFSTWD | 371 | Q9Y5C1 | |
| FLATWKDIPNENEAQ | 846 | Q10567 | |
| TFWNLPNSAQTNIDV | 26 | Q14002 | |
| LILDANDNAPQFLWD | 881 | Q9NYQ6 | |
| SATLSPQVINEVWQE | 191 | Q96QD5 | |
| DVNWANSEENKATPL | 631 | Q15057 | |
| LTNLEQPRTESEWEN | 576 | Q32M45 | |
| EDSSLQWSNPAQQTL | 56 | Q8N126 | |
| AETNSTDLLSQPWNE | 6 | Q16581 | |
| QSTQPVVQDADWLAS | 1701 | Q9P2D1 | |
| ADTVVIFDSDWNPQN | 876 | O14646 | |
| IFDSDWNPQNDLQAQ | 881 | O14646 | |
| DWSQPSVVFQDDSLE | 1951 | Q9Y485 | |
| TWLSQQNEEPVFSRD | 366 | Q8N608 | |
| DASDWLNPAQVVLFS | 436 | O14525 | |
| FPQTATEWAEILALQ | 656 | Q96CP6 | |
| DINNNFPDLNTLLWE | 451 | Q8N436 | |
| IADAWNAIPDNLDAV | 606 | P08253 | |
| LTGTESPFDLEQQWQ | 301 | Q14494 | |
| DFDNSPVLQDWVTAT | 231 | O95631 | |
| QFQPTQDNVEREETW | 291 | Q86YV0 | |
| TWFSLQPVDSNSEVQ | 136 | Q15283 | |
| TQAAAIPEAWLTAFQ | 116 | Q53FA7 | |
| EVEWDAFSIPELQNF | 366 | Q8WWW0 | |
| EPFLAQARLAWEAQQ | 551 | Q9C0H5 | |
| QNPTAEEVLSWSQNF | 71 | Q9UGC6 | |
| LDPQTLDTEQQWDTP | 301 | Q9NRN5 | |
| IEWQTADVIVNSVNP | 326 | Q8IXQ6 | |
| IQQDWKPSFLSNEEF | 71 | Q99743 | |
| ANLSFLIPDTITQWE | 641 | Q6IE37 | |
| WINVQDRPNDVESLV | 311 | Q8TDY2 | |
| DDNPSLQFEAAWALT | 126 | O00505 | |
| NQEWVVQADLPLTAA | 271 | Q674X7 | |
| KELLFQEPNANSVAW | 546 | Q9HBG6 | |
| ENNVFIKWPDTNDIV | 1291 | Q2M2H8 | |
| PQDVTETSWQIEINE | 586 | O43187 | |
| SDSFNPTLWEEQRQQ | 441 | Q96NW7 | |
| EQIDWQEITFADNQP | 1631 | Q9UKN7 | |
| DSLTVVFENNWQPER | 26 | P51114 | |
| NEALVPVNSSLQEAW | 571 | Q9BQS8 | |
| PNVTWIDLGNNVDIF | 261 | Q8NAA5 | |
| LNKTDPANQFEWLES | 221 | Q92484 | |
| PANQFEWLESTLNNS | 226 | Q92484 | |
| DSVDFDQWFKNQLLP | 466 | Q9UI26 | |
| QTSIFLQEWDIPFEQ | 651 | Q6VAB6 | |
| SAEAAAPEWNEQLSF | 241 | A9Z1Z3 | |
| IFNSLWNLDQTKVEP | 156 | Q9NQG7 | |
| RTQVQQPSDENWDLT | 1246 | O15054 | |
| LWNLNNDTEVPTASI | 551 | Q13409 | |
| DFIPNAWQQELLDVV | 741 | Q5H9U9 | |
| QENVFDLQWLELPDV | 166 | Q9P219 | |
| QEAFSIQLISPVSWE | 1071 | Q10570 | |
| VSVVWQLEENAFPNR | 921 | P38570 | |
| PQWINVLQEDSVTLT | 56 | P31995 | |
| DLPNWSNENVDDRLN | 16 | Q15154 | |
| SEAQPDLSILQAWSQ | 131 | Q6UW60 | |
| LTVNVKDWNDNAPRF | 806 | Q9NYQ8 | |
| ESLQSLFSEWDNPVF | 1136 | Q9UHC1 | |
| SSQLPNVDEQVQAWE | 541 | Q9H5P4 | |
| QELRTSTVWDNNNPI | 446 | P14222 | |
| ADVDLQWNFSQTPIE | 181 | Q32MH5 | |
| SQLQETWLAEAQVPD | 51 | P50549 | |
| QLWQFLVALLDDPSN | 336 | P50549 | |
| LQNDPEEWVAVSDAT | 21 | A0A1B0GUQ0 | |
| PEEVTDWLQAENFST | 531 | Q8TE67 | |
| WIPFNSEDSQQLEEA | 56 | O94830 | |
| IAQDLDWNEPALIDQ | 191 | Q86TG7 | |
| LNPENLELEQTWETN | 406 | Q99972 | |
| WAEEATNLQVNSPAV | 686 | Q6ZMV9 | |
| QPWQEDETQAEDTSI | 266 | Q0VF49 | |
| LQWRSSPAADAQEEN | 516 | Q8N423 | |
| WLDISSNNLTDLPQD | 241 | Q9BYS8 | |
| DNFTQSLLNTWDPKV | 461 | P48552 | |
| ANDSQLTPLEEWSNN | 1036 | Q8NG31 | |
| QSPQEWEAIQALTVL | 56 | Q9UJY5 | |
| IENSPSVWQNILESD | 1041 | P00451 | |
| SQLQEAWLAEAQVPD | 51 | P41161 | |
| VETPENLAVDWVNNK | 466 | P98164 | |
| LSQEFGWLQITPQEF | 791 | P10275 | |
| NLSFLIPDTITQWEA | 741 | Q6IE36 | |
| EFLEPDSWETLDQQQ | 326 | P80303 | |
| AWVEKPTEQDQFSLT | 726 | P78563 | |
| VWDQPEDLNLFFTAT | 386 | P18084 | |
| ASLQSPFEQTNWKEL | 466 | O95402 | |
| PFEQTNWKELSRNEI | 471 | O95402 | |
| DESNLSPSEVVQWSN | 706 | Q8ND30 | |
| ALPENVILVNTTDWQ | 561 | Q6VY07 | |
| QLSQELPEAFWSTSN | 296 | Q9NY74 | |
| ASQPQAEFQLTWLDL | 236 | Q14392 | |
| QQQDTWEVPFEEISE | 156 | O43283 | |
| PEWNESFNFQIQSRV | 116 | Q3MJ16 | |
| QEQLTSVDWPESFVA | 386 | Q6GPH6 | |
| IFAAIDNDLQPSWQE | 171 | Q9UP65 | |
| TEATSDWLNANNVPA | 1391 | P31327 | |
| NRTDISLDDPNFWQK | 1411 | Q3L8U1 | |
| DSITVAFENNWQPDR | 26 | Q06787 | |
| TWTLNPQIDNEALFS | 306 | Q96ID5 | |
| TRQWQDVESLPLIDN | 531 | Q9NVR0 | |
| IQPRSWENSKFDFDN | 1106 | Q13936 | |
| LLEPFIAVSAQAWNQ | 241 | P55265 | |
| WQSVEQLPEAALAQT | 241 | A6NNT2 | |
| ISENDPFWNQLLSFS | 26 | Q7RTS9 | |
| TVVIFDSDWNPQNDL | 881 | O14647 | |
| IFDSDWNPQNDLQAQ | 876 | Q8TD26 | |
| NRTDISLDDPNFWQK | 1011 | Q8TD26 | |
| LQNDPEEWVAVSDAT | 21 | A0A1B0GV22 | |
| VIIFDSDWNPHNDIQ | 1151 | Q12873 | |
| EEEQPLWAANENSVQ | 451 | Q8IW35 | |
| NNRFLPWNEIETEAI | 726 | O43909 | |
| EWLISPADNQKVDQV | 56 | P78310 | |
| VAQDNTENPDLSIIW | 306 | P31415 | |
| EQFSSDFLPLWAQSE | 196 | Q8TAL5 | |
| QDSWDSFPLFQLLNN | 896 | Q86UW7 | |
| ELSEQQLQLWPSDVD | 301 | P09543 | |
| FDWIEANLSEQQIVS | 1461 | Q04637 | |
| AETVAEAWVSQNPNS | 511 | O00462 | |
| WEQLASSVPEILQFN | 621 | P10253 | |
| WSQPQRFSIEVQVSD | 531 | P42701 | |
| WINPVDFQEEASLQE | 601 | P42701 | |
| DQVWNIFSEASNSEP | 131 | Q9NX58 | |
| VPFLDSNQENDLLWE | 106 | Q9NYP3 | |
| SNQENDLLWEEKFPE | 111 | Q9NYP3 | |
| SQNPNVRWDDIADLV | 201 | O75449 | |
| FWEAQAPVSTVEQLD | 206 | Q9Y6V7 | |
| EWSDPVIFQTQSEEL | 216 | Q9HBE5 | |
| ELNPDQINLFNWAID | 1211 | Q5TBA9 | |
| PISEELQLVWTQAAQ | 46 | Q8IX15 | |
| STQQVLDWFDSRLPQ | 491 | Q8IX15 | |
| VIPETSEENNEDIWN | 76 | Q9NQM4 | |
| FTDISPENTLPNQEW | 531 | Q5W0V3 | |
| EQAQNELSAWKFTPD | 136 | Q15007 | |
| QPSSREEAQQLWEAE | 786 | Q14289 | |
| LPNESTLFDQVNSNW | 1466 | Q9P225 | |
| LELANRFPQQAWEEA | 1376 | Q9BY12 | |
| QLDAAAPTVSFEAQW | 841 | Q8TDX9 | |
| EAWTQQVATENPALI | 126 | P15086 | |
| KQWNLASPSEETLNE | 871 | Q08AD1 | |
| LFPQSQANIWLFEDT | 166 | Q6P995 | |
| KEESDVPQWSSQFLQ | 306 | Q96FZ2 | |
| NFWNLPTTAQVTIEA | 26 | P11464 | |
| NFWNLPTTAQVTIEA | 26 | Q16557 | |
| QAWASIELDPQSSNL | 261 | Q95460 | |
| DINPVWNETFEFILD | 66 | P47712 | |
| WNETFEFILDPNQEN | 71 | P47712 | |
| SAWSNIQEAPLQDDS | 331 | Q9Y2M0 | |
| EQPLQNGFEELIQWT | 291 | Q92665 | |
| SVDLQSENPWDNKAV | 196 | Q86TM6 | |
| RQPNSLDFVTQWLEE | 256 | Q9NUJ3 | |
| EVRTQLLQPADENWD | 946 | O14607 | |
| LFQLWTAEPLDQAAA | 536 | Q9HAU8 | |
| EFILNQDWNDPKSQL | 1251 | Q9NRR4 | |
| VAQWQADFNSLPDDL | 1081 | Q9C093 | |
| WNTTEVAPALSVFND | 596 | O43815 | |
| QTPVKQNTAWEFEES | 451 | Q9HCJ0 | |
| LDINIQEPRWDQSTF | 6 | Q9BWM7 | |
| PEDAFNFNNWVTLLS | 61 | Q14542 | |
| NSPSEINNEAAPEIW | 851 | Q8WUY3 | |
| QAADTVVIFDSDWNP | 1136 | P51531 | |
| VVIFDSDWNPHQDLQ | 1141 | P51531 | |
| DRLEFWTQQSVTVPQ | 6816 | Q8NF91 | |
| SQWTDLLTNIPAVQE | 6886 | Q8NF91 | |
| NWDPVDQTVLANEQV | 206 | Q15031 | |
| DTDEDTAVNNWLISP | 961 | P12259 | |
| LIIQVWDNDIFSPDD | 1816 | A0AVI2 | |
| EDTIPQLLVDFWEAQ | 771 | Q969F9 | |
| LALAFQANPNSEEIW | 631 | O94906 | |
| NFWNLPTTAQVIIEA | 26 | Q00889 | |
| PTLEEVNAWAQSFDK | 251 | O76081 | |
| TNDLFPWLNDQENTS | 911 | Q9NTG1 | |
| KVWLDPNETNEIANA | 21 | P84098 | |
| QSADTVIIFDSDWNP | 1166 | P51532 | |
| VIIFDSDWNPHQDLQ | 1171 | P51532 | |
| FETVAQEWLNSPNRE | 1756 | Q7Z333 | |
| LQERFQVLNPTWSAE | 181 | Q9Y6E7 | |
| ADSLNQVSTIWDDNP | 126 | Q9Y2G9 | |
| PESVQLQDSWVLNSN | 296 | Q9NT68 | |
| LQDSWVLNSNVPLET | 301 | Q9NT68 | |
| QAWDSVDLDNPQENI | 41 | P51692 | |
| EISEPINFDNDSSIW | 651 | Q8IXF0 | |
| PWVDTNDEETIQQQI | 126 | Q96A49 | |
| PISNQSWDQKFTLEL | 411 | Q16513 | |
| NQPWLEQLFDSFSDL | 2011 | Q9ULL5 | |
| PRQAAFQEQLASELW | 2001 | Q6ZRS2 | |
| QLPWSELTQTLEESQ | 1216 | Q9Y2I6 | |
| LPDERNDTLEWENQQ | 926 | Q4LDE5 | |
| QESRFVDWPTFLQEN | 366 | Q9UPV7 | |
| ASAISNWVQFEDDTP | 96 | Q8WXE9 | |
| STDPQDFIQEWLRSQ | 461 | Q92925 | |
| LWLEDQSQPNATLSA | 96 | B2RD01 | |
| SRQTQDWVLQSFEEP | 266 | Q9P2M7 | |
| ENDQVWLQLPNAESN | 646 | Q03692 | |
| VDKNFINSPVAQADW | 16 | P35749 | |
| IILQVDSEENNTTWP | 1061 | Q9BXT8 | |
| SAPALDVDWQNNTTF | 371 | O60907 | |
| SIRWIFENQPLDSIN | 401 | A4UGR9 | |
| NDPQWSEEQLIAAKF | 136 | P22234 | |
| WANTTDPEKLIQFLQ | 216 | Q63HM9 | |
| VNFTLEEWALLDPSQ | 11 | Q8TBZ8 | |
| SNIVVQPIVNEDFLW | 391 | Q8N2E2 | |
| DFTQEEWEQLDPSQR | 16 | Q6P2D0 | |
| VNFTQEEWALLGPSQ | 11 | P16415 | |
| VNFTQEEWALLDISQ | 11 | Q8IYI8 | |
| FAQDLWPEQNIKDSF | 81 | P35789 | |
| DLWPEQDIKDSFQQV | 56 | Q96N38 | |
| EQFLSALPADTQAWV | 66 | Q8N0Y2 | |
| FTQEEWALLDPSQKN | 16 | P17024 | |
| VSFSQEEWALLAPSQ | 11 | Q3KP31 | |
| QQIWEEIASDLTRPQ | 101 | Q9UK11 | |
| VNFTQEEWALLDPSQ | 11 | P52737 | |
| VDFSQEEWALLDPAQ | 21 | Q13360 | |
| TVNFTQEEWQQLDPA | 16 | Q9HCZ1 | |
| FDVWQNVTPLTFEEV | 156 | P51512 | |
| DIFQNQWGLSFINEP | 501 | Q7Z417 | |
| TAVLEESDQPLNEFW | 31 | Q5GAN6 | |
| DDVESQFPAWISQFL | 451 | Q9UH99 | |
| QDDPNVLEIWNLVFI | 206 | P49588 | |
| EVQWNPFDTESFLVS | 311 | Q96MK2 | |
| EEPQWSFAFEQILAS | 1071 | Q0IIM8 | |
| ATLNSQITFWDPENA | 561 | Q15269 | |
| QITFWDPENAVQTGS | 566 | Q15269 | |
| EIPQDQNAAESWETL | 161 | P56962 | |
| QSLQGPQWQSVEEAF | 641 | Q8WWL2 | |
| LQPATVDNWSQIQSF | 21 | O00338 | |
| VDNWSQIQSFEAKPD | 26 | O00338 | |
| ADPDTLVNWDFVEQV | 201 | Q8N5U6 | |
| PEESEWLETTQLQQS | 171 | Q8NBB4 | |
| VDFTLEEWALLNPAQ | 11 | Q9HAH1 | |
| QLVEDPHWNFQEETL | 586 | Q5VUG0 | |
| TEEFQWPQRSQTLAQ | 881 | Q5T1R4 | |
| IEFSLEEWEFLNPAQ | 11 | O95780 | |
| DQPQETAQDLSLWKE | 376 | Q9HCK1 | |
| SETILWDVQTDSNPN | 881 | Q8IZM8 | |
| VEDQTLWSDPIRTNQ | 176 | O75631 | |
| VNFTLEEWALLDPSQ | 11 | Q7L945 | |
| ATWRQEFPKLSQEAQ | 326 | A6NKC9 | |
| EEENQENLDWVPLTT | 346 | Q2T9K0 | |
| LLFSSDEEDQWNIPA | 616 | Q9Y4E1 | |
| WLEDAFQLAVNVNSP | 266 | Q96RU2 | |
| NLRNLPWFDEVDANS | 111 | Q9Y4R7 | |
| GSPIQAWQLFVNEES | 336 | P01833 | |
| VNFTQEEWALLGPSQ | 11 | Q8N972 | |
| SSLFALQNLQPWEED | 266 | O43711 | |
| LKELPSEQQEQWEAF | 491 | Q9UPN7 | |
| VNFTQEEWSLLDPSQ | 11 | Q08AG5 | |
| NFTQEEWALLDPSQK | 21 | Q15973 | |
| WIFVNALIENPTFDS | 361 | P11388 | |
| RTNPSQLNAVEFLWD | 161 | Q9NZI7 | |
| VNFTQEEWALLGPSQ | 36 | Q9H7R0 | |
| SSLFALQNLQPWSDD | 301 | P31314 | |
| QLIFVNDLDISAPQW | 241 | Q96HH6 | |
| VNFTQEEWALLGPSQ | 11 | Q8TA94 | |
| LLFSSDEEDQWNIPA | 616 | Q641Q2 | |
| SWDPEQNEVVQSSEK | 961 | P86452 | |
| WTNENEAALTPLALD | 346 | Q9UHR6 | |
| VNFTQEEWALLSPSQ | 11 | Q8IZC7 | |
| VTETERNSQNPALEW | 1656 | Q7Z7G8 | |
| VNFTQEEWALLDISQ | 31 | Q9UC07 | |
| LPFSQEQEILWAIND | 106 | P36537 | |
| ILFTQEEWGQLSPAQ | 21 | Q8N9F8 | |
| FNQDLWPEQSIKDSF | 81 | Q6ZN08 | |
| QQDPSQIDWAALAQA | 26 | Q8TF01 | |
| NFWNLPTTAQVTIEA | 26 | P11465 | |
| STNPAVQAFDIWLNS | 216 | A0AVI4 | |
| FLDGFNEVVPLQWLQ | 776 | Q9H0M0 | |
| VNFTQEEWALLDISQ | 11 | Q0D2J5 | |
| EEFQWPQRSETLSQL | 916 | P31629 | |
| FTQEEWQQLDPAQKA | 16 | Q96SR6 | |
| LNQQTWVRTDSAPDQ | 661 | Q5T5U3 | |
| NFWNLPITAQVTIEA | 26 | Q15238 | |
| LSDNENPWTIFLETV | 651 | Q93009 | |
| FTQEEWALLDPSQKN | 16 | Q8N7K0 | |
| TKPETFNQLWTVEEQ | 646 | Q8IYH5 | |
| FSQDQWSDLDPTQKE | 246 | O95125 | |
| VAVDFTLEEWQLLNP | 11 | Q86T29 | |
| SIIELQNKTPVWNDD | 421 | P50607 | |
| QSLPEQSSDALEAWE | 81 | O75888 | |
| DFTQEEWQQLDPSQR | 16 | Q96RE9 | |
| NQWETPPEDLQTDLA | 271 | Q6P9G9 | |
| SPFDEFNLWRSQVDN | 786 | Q9UNY4 | |
| VAFTQEEWALLDPSQ | 11 | Q9BS34 | |
| VNFTQEEWALLDPSQ | 11 | C9JN71 | |
| NESQNPLLANEETWE | 301 | Q96MV8 | |
| QASSLNVEEFQDLWP | 201 | Q86U90 | |
| NVEEFQDLWPQLSLV | 206 | Q86U90 | |
| TQDLWPDQSTKDSFQ | 91 | A6NN14 | |
| VNFTQEEWALLDISQ | 26 | Q8NDP4 | |
| DDNPSLQFEAAWALT | 126 | O00629 | |
| DIFAIASIANPDWIN | 16 | Q8NHV5 | |
| EDLVFTDASPQAVWN | 5251 | O14686 | |
| TLNPTWDQTIIFDEV | 1181 | Q9NZM1 |